Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04513028
Status:
RECRUITING
Last Update Posted:
2024-05-24
First Post:
2020-07-30
Brief Title:
Beta Glucans Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Sponsor:
Kelly McMasters
Organization:
University of Louisville
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Melanoma Stage IV |
| Melanoma Stage III |
Keywords: